Randhawa Simrat 4
4 · Dianthus Therapeutics, Inc. /DE/ · Filed Sep 25, 2023
Insider Transaction Report
Form 4
Randhawa Simrat
EVP, Head of R&D
Transactions
- Purchase
Common Stock
2023-09-22$13.20/sh+2,000$26,400→ 4,000 total - Purchase
Common Stock
2023-09-21$13.20/sh+2,000$26,400→ 2,000 total